Cytokine profile and pathology in human leishmaniasis

Brazilian Journal of Medical and Biological Research

Volumn 31, Issue 1, 1998, Pages 143-148

  Ribeiro de Jesus, A ^a   Almeida, R P ^a   Lessa, H ^a   Bacellar, O ^a   Carvalho, E M ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Cytokines; Human leishmaniasis; Immunological responses; Leishmaniasis; Pathology

Indexed keywords

LEISHMANIA AMAZONENSIS; LEISHMANIA DONOVANI CHAGASI;

CYTOKINE; GAMMA INTERFERON;

ANIMAL; ARTICLE; HUMAN; IMMUNOLOGY; LEISHMANIA; LEISHMANIASIS; PATHOGENICITY; PHYSIOLOGY;

ANIMALS; CYTOKINES; HUMANS; INTERFERON TYPE II; LEISHMANIA; LEISHMANIASIS;

EID: 0031610015     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1998000100020     Document Type: Article

References (37)

1. Lainson R & Shaw JJ (1978). Epidemiology and ecology of leishmaniasis in Latin-America. Nature, 273: 595-600.
2. Marsden PD (1979). Current concepts in parasitology. Leishmaniasis. New England Journal of Medicine, 300: 350-352.
3. Barrai A, Pedral-Sampaio D, Grimaldi G, Momen H, McMahon-Pratt D, Ribeiro de Jesus A, Almeida R, Badaró R, Barral-Netto M, Carvalho EM & Johnson WD (1991). Leishmaniasis in Bahia, Brazil: Evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. American Journal of Tropical Medicine and Hygiene, 44: 536-546.
4. Grimaldi GJ. David JR & McMahon PD (1987). Identification and distribution of New World Leishmania species characterized by serodeme analysis using monoclonal antibodies [published erratum appears in American Journal of Tropical Medicine and Hygiene, 37: 414, 1987]. American Journal of Tropical Medicine and Hygiene, 36: 270-287.
5. Grimaldi GJ, Momen H, Naiff RD, McMahon PD & Barrett TV (1991). Characterization and classification of leishmanial parasites from humans, wild mammals, and sand flies in the Amazon region of Brazil. American Journal of Tropical Medicine and Hygiene, 44: 645-661.
6. Convit J, Pinardi ME & Randon AJ (1972). Diffuse cutaneous leishmaniasis: A disease due to an immunological defect of the host. Transactions of the Royal Society of Tropical Medicine and Hygiene, 66: 603-610.
7. Badaró R, Carvalho EM, Rocha H, Queiroz AC & Jones TC (1986). Leishmania donovani: An opportunistic microbe associated with progressive disease in three immunocompromised patients. Lancet, 1: 647-648.
8. Scott P (1991). Interferon gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. Journal of Immunology. 147: 3149-3155.
9. Heinzel FP, Sadick MD, Holaday RL, Coffman RL & Locksley RM (1989). Reciprocal expression of IFN-γ or IL-4 during the resolution or progression of murine leishmaniasis. Evidence for expression of distinct helper T cell subsets. Journal of Experimental Medicine. 169: 59-72.
10. Heinzel FP, Sadick MD, Mutha SS & Locksley RM (1991). Production of IFN-γ, IL-2, IL-4 and IL-10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proceedings of the National Academy of Sciences, USA. 80: 7011-7015.
11. Chatelain R, Varkila K & Coffman RL (1992). Interleukin-4 induces a Th2 response in L. major infected mice. Journal of Immunology, 148: 1182-1187.
12. Belosevic M, Finbloom DS, Van Der Meide PH, Slayter MV & Nacy CA (1989). Administration of monoclonal anti IFN-γ antibodies in vivo abrogates natural resistance of C3H/NeN mice to infection with Leishmania major. Journal of Immunology. 143: 266-271
13. Carvalho EM, Barrai A, Pedral-Sampaio D, Barral-Netto M, Badaró R, Rocha H & Johnson WD (1992). Immunologic markers of clinical evolution in children recently infected with L. donovani chagasi. Journal of Infectious Diseases. 165: 535-540.
14. Zwingenberger K, Harms G, Pedrosa C, Omena S, Sandkamp B & Neifer S (1990) Determinants of the immune response in visceral leishmaniasis: evidence for predominance of endogenous interleukin 4 over interferon-γ production. Clinical Immunology and Immunopathology. 57: 242-249.
15. Ghalib HW, Piuvezam MR, Sheiky Y, Siddig M, Hashim FA, El Hassan AM, Russo DM & Reed SG (1993). Interleukin-10 production correlates with pathology in human Leishmania donovani infections. Journal of Clinical Investigation. 92: 324-329.
16. Karp CL, El Safi SH, Wynn TA, Satti MM, Kordofani AM, Hashim FA, Hag-Ali M, Neva FA, Nutman TB & Sacks DL (1993). In vivo cytokine profiles in patients with kala-azar. Journal of Clinical Investigation. 91: 1644-1648.
17. Holaday BJ, Pompeu MM, Jeronimo S, Teixeira MJ & Sousa A de A (1993). Potential role for IL-10 in the immune suppression associated with kala-azar. Journal of Clinical Investigation. 92: 2626-2632.
18. Carvalho EM, Bacellar O, Brownell C, Regis T, Coffman RL & Reed SG (1994). Restoration of IFN-γ production and lymphocyte proliferation in visceral leishmaniasis. Journal of Immunology, 152: 5949-5956.
19. Ghalib HW, Whitle JA, Kubim M, Hashim FA, El-Hassan BM, Grabstein G, Trinchier; G & Reed SG (1995). Interleukin-12 enhances Th1 type immune response in human Leishmania donovani infection. Journal of Immunology, 154: 4623-4629.
20. Bacellar O, Brodskyn C, Guerreiro J, Barral-Netto M, Costa CH, Coffman RL, Johnson WD & Carvalho EM (1996). Interleukin-12 restores interferon-γ production and cytotoxic responses in visceral leishmaniasis. Journal of Infectious Diseases, 173: 1515-1518.
21. Bogdan C, Vodovotz Y & Nathan C (1991). Macrophage deactivation by IL-10. Journal of Experimental Medicine, 174: 1549-1560.
22. Castés M, Agnelli A, Verde O & Rondon AJ (1983). Characterization of the cellular immune response in American cutaneous leishmaniasis. Clinical Immunology and Immunopathology, 27: 176-186.
23. Carvalho EM, Johnson WD, Barreto E, Marsden PD, Costa JML, Reed S & Rocha H (1985). Cell mediated immunity in American cutaneous and mucosal leishmaniasis. Journal of Immunology, 135: 4144-4148.
24. Coutinho SG, Pirmez C, Mendonça SCF, Conceição-Silva F & Doréa RCC (1987). Pathogenesis and immunopathology of leishmaniasis. Memóries do Instituto Oswaldo Cruz, 82 (Suppl I): 214-228.
25. Mendonça SCF, Coutinho SG, Amendoeira MRR, Marzochi MCA & Pirmez C (1986). Human American cutaneous leishmaniasis (Leishmania braziliensis braziliensis) in Brazil: lymphoproliferative response and influence of therapy. Clinical and Experimental Immunology, 64: 269-275.
26. Pirmez C, Yamamura M, Uyemura K, Paes-Oliveira M, Conceição-Silva F & Modlin RL (1993). Cytokine patterns in the pathogenesis of human leishmaniasis. Journal of Clinical Investigation, 91: 1390-1395.
27. Cáceres-Dittmar G, Tapia FJ, Sanchez MA, Yamamura M, Uyemura K, Modlin RL, Bloom BR & Convit J (1993). Determination of the cytokine profile in American cutaneous leishmaniasis using polymerase chain reaction. Clinical and Experimental Immunology, 91: 500-505.
28. Melby PC, Andrade Narvaez FJ, Darnell BJ, Balencia Pacheco G, Tryon VV & Palomo-Cetina A (1994). Increased expression of pro-inflammatory cytokines in chronic lesions of human cutaneous leishmaniasis. Infection and Immunity, 62: 837-842.
29. Almeida RP, Rocha P, Jesus AR, Costa J & Carvalho EM (1995). Evaluation of cellular immune responses in patients with different clinical forms of tegumentary leishmaniasis. Allergy Journal of Immunology, 14: 11-19.
30. Castés M, Trujillo D, Rojas ME, Fernandez CT, Araya L, Cabrera M, Blackwell J & Convit J (1993). Serum levels of tumor necrosis factor in patients with American cutaneous leishmaniasis. Biological Research. 26: 233-238.
31. Da-Cruz AM, de-Oliveira MP, De-Luca PM, Mendonça SC & Coutinho SG (1996). Tumor necrosis factor-alpha in human American tegumentary leishmaniasis. Memórias do Instituto Oswaldo Cruz, 91: 225-229.
32. Strieter RM, Remick DG, Ward PA, Spengler RN, Lynch JP, Larrich J & Kunkel SL (1988). Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochemical and Biophysical Research Communications, 153: 1230-1236.
33. Doherty GM, Jensen JC, Alexander HR, Buresh CM & Norton JA (1991). Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery, 110: 192-198.
34. Liew FY, Li Y & Millott S (1990). Tumor necrosis factor α synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide. Journal of Immunology, 145: 4306-4310.
35. Liew FY, Parkinson C, Millott S, Severn A & Carrier M (1990). Tumor necrosis factor (TNF-α) in leishmaniasis. I. TNF-α mediates host protection against cutaneous leishmaniasis. Immunology, 69: 570-573.
36. Titus RG, Sherry B & Cerami A (1989). Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. Journal of Experimental Medicine, 170: 2097-2104.
37. Carvalho EM, Correia Filho D, Bacellar O, Lessa H & Rocha H (1995). Characterization of the immune response in subjects with self healing cutaneous leishmaniasis. American Journal of Tropical Medicine and Hygiene, 53: 273-277.